93 related articles for article (PubMed ID: 7899792)
1. The activity and ultrastructural localization of primaquine-loaded poly (d,l-lactide) nanoparticles in Leishmania donovani infected mice.
Rodrigues JM; Croft SL; Fessi H; Bories C; Devissaguet JP
Trop Med Parasitol; 1994 Sep; 45(3):223-8. PubMed ID: 7899792
[TBL] [Abstract][Full Text] [Related]
2. Drug targeting with polyalkylcyanoacrylate nanoparticles: in vitro activity of primaquine-loaded nanoparticles against intracellular Leishmania donovani.
Gaspar R; Opperdoes FR; Préat V; Roland M
Ann Trop Med Parasitol; 1992 Feb; 86(1):41-9. PubMed ID: 1616394
[TBL] [Abstract][Full Text] [Related]
3. Oleanolic acid loaded poly lactic co- glycolic acid- vitamin E TPGS nanoparticles for the treatment of Leishmania donovani infected visceral leishmaniasis.
Ghosh S; Kar N; Bera T
Int J Biol Macromol; 2016 Dec; 93(Pt A):961-970. PubMed ID: 27645930
[TBL] [Abstract][Full Text] [Related]
4. In vivo and in vitro antileishmanial activity of Bungarus caeruleus snake venom through alteration of immunomodulatory activity.
Bhattacharya S; Ghosh P; De T; Gomes A; Gomes A; Dungdung SR
Exp Parasitol; 2013 Sep; 135(1):126-33. PubMed ID: 23830987
[TBL] [Abstract][Full Text] [Related]
5. Effect of allicin on promastigotes and intracellular amastigotes of Leishmania donovani and L. infantum.
Jesús Corral-Caridad M; Moreno I; Toraño A; Domínguez M; Alunda JM
Exp Parasitol; 2012 Dec; 132(4):475-82. PubMed ID: 22995646
[TBL] [Abstract][Full Text] [Related]
6. In vivo antileishmanial action of Ir-(COD)-pentamidine tetraphenylborate on Leishmania donovani and Leishmania major mouse models.
Loiseau PM; Mbongo N; Bories C; Boulard Y; Craciunescu DG
Parasite; 2000 Jun; 7(2):103-8. PubMed ID: 10887656
[TBL] [Abstract][Full Text] [Related]
7. Characterization and evaluation of BNIPDaoct-loaded PLGA nanoparticles for visceral leishmaniasis: in vitro and in vivo studies.
Costa Lima SA; Resende M; Silvestre R; Tavares J; Ouaissi A; Lin PK; Cordeiro-da-Silva A
Nanomedicine (Lond); 2012 Dec; 7(12):1839-49. PubMed ID: 22812711
[TBL] [Abstract][Full Text] [Related]
8. The activity of platinum, iridium and rhodium drug complexes against Leishmania donovani.
Croft SL; Neal RA; Craciunescu DG; Certad-Fombona G
Trop Med Parasitol; 1992 Mar; 43(1):24-8. PubMed ID: 1598504
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic efficacy of artemisinin-loaded nanoparticles in experimental visceral leishmaniasis.
Want MY; Islamuddin M; Chouhan G; Ozbak HA; Hemeg HA; Dasgupta AK; Chattopadhyay AP; Afrin F
Colloids Surf B Biointerfaces; 2015 Jun; 130():215-21. PubMed ID: 25936561
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo antileishmanial properties of a 2-n-propylquinoline hydroxypropyl β-cyclodextrin formulation and pharmacokinetics via intravenous route.
Balaraman K; Vieira NC; Moussa F; Vacus J; Cojean S; Pomel S; Bories C; Figadère B; Kesavan V; Loiseau PM
Biomed Pharmacother; 2015 Dec; 76():127-33. PubMed ID: 26653559
[TBL] [Abstract][Full Text] [Related]
11. Activity of pentamidine-loaded poly (D,L-lactide) nanoparticles against Leishmania infantum in a murine model.
Durand R; Paul M; Rivollet D; Fessi H; Houin R; Astier A; Deniau M
Parasite; 1997 Dec; 4(4):331-6. PubMed ID: 9587601
[TBL] [Abstract][Full Text] [Related]
12. Activities of hexadecylphosphocholine (miltefosine), AmBisome, and sodium stibogluconate (Pentostam) against Leishmania donovani in immunodeficient scid mice.
Escobar P; Yardley V; Croft SL
Antimicrob Agents Chemother; 2001 Jun; 45(6):1872-5. PubMed ID: 11353640
[TBL] [Abstract][Full Text] [Related]
13. Amphotericin B inhibits entry of Leishmania donovani into primary macrophages.
Paila YD; Saha B; Chattopadhyay A
Biochem Biophys Res Commun; 2010 Aug; 399(3):429-33. PubMed ID: 20678487
[TBL] [Abstract][Full Text] [Related]
14. Development and evaluation of a cedrol-loaded nanostructured lipid carrier system for in vitro and in vivo susceptibilities of wild and drug resistant Leishmania donovani amastigotes.
Kar N; Chakraborty S; De AK; Ghosh S; Bera T
Eur J Pharm Sci; 2017 Jun; 104():196-211. PubMed ID: 28400285
[TBL] [Abstract][Full Text] [Related]
15. A new approach for the delivery of artemisinin: formulation, characterization, and ex-vivo antileishmanial studies.
Want MY; Islamuddin M; Chouhan G; Dasgupta AK; Chattopadhyay AP; Afrin F
J Colloid Interface Sci; 2014 Oct; 432():258-69. PubMed ID: 25086720
[TBL] [Abstract][Full Text] [Related]
16. Leishmanicidal activity of stearylamine-bearing liposomes in vitro.
Afrin F; Dey T; Anam K; Ali N
J Parasitol; 2001 Feb; 87(1):188-93. PubMed ID: 11227889
[TBL] [Abstract][Full Text] [Related]
17. The antileishmanial properties of surface-modified, primaquine-loaded nanocapsules tested against intramacrophagic Leishmania donovani amastigotes in vitro.
Heurtault B; Legrand P; Mosqueira V; Devissaguet JP; Barratt G; Bories C
Ann Trop Med Parasitol; 2001 Jul; 95(5):529-33. PubMed ID: 11487374
[No Abstract] [Full Text] [Related]
18. Targeted chemotherapy of visceral leishmaniasis by lactoferrin-appended amphotericin B-loaded nanoreservoir: in vitro and in vivo studies.
Asthana S; Gupta PK; Jaiswal AK; Dube A; Chourasia MK
Nanomedicine (Lond); 2015; 10(7):1093-109. PubMed ID: 25929567
[TBL] [Abstract][Full Text] [Related]
19. Efficacies of vesicular and free sodium stibogluconate formulations against clinical isolates of Leishmania donovani.
Carter KC; Mullen AB; Sundar S; Kenney RT
Antimicrob Agents Chemother; 2001 Dec; 45(12):3555-9. PubMed ID: 11709339
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo antileishmanial efficacy of a new nitrilquinoline against Leishmania donovani.
Nakayama H; Desrivot J; Bories C; Franck X; Figadère B; Hocquemiller R; Fournet A; Loiseau PM
Biomed Pharmacother; 2007; 61(2-3):186-8. PubMed ID: 17360145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
